Uveitis, Intermediate: all 56 studies

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Adalimumab Dose Adjustment for Pediatric Uveitis Treatment TrialNot yet recruitingNCT07699107Phase 4
• Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept StudyRecruitingNCT06085079Phase 4
• Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) InsertTerminatedNCT05070728Phase 3Results posted
• Adalimumab in JIA-associated Uveitis Stopping TrialCompletedNCT03816397Phase 4Results posted
• Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)TerminatedNCT03656692Phase 4Results posted
• Suprachoroidal Injection of CLS-TA in Patients With Non-infectious UveitisCompletedNCT03097315Phase 3Results posted
• MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301CompletedNCT02952001Results posted
• Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)CompletedNCT02911116Phase 2Results posted
• Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis PatientsCompletedNCT02764697Phase 4Results posted
• Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior UveitisCompletedNCT02746991Phase 3Results posted
• Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisCompletedNCT02595398Phase 3Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisCompletedNCT02255032Phase 2Results posted
• Study of the Effectiveness of Ozurdex for the Control of UveitisCompletedNCT02049476Phase 4Results posted
• Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat UveitisCompletedNCT01789320Phase 1/2Results posted
• Topical Interferon Gamma for Macular Edema Secondary to UveitisCompletedNCT01376362Phase 1/2Results posted
• A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitisCompletedNCT01148225Phase 3Results posted
• Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisTerminatedNCT01095250Phase 3Results posted
• Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious UveitisTerminatedNCT01090310Phase 3Results posted
• Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious UveitisTerminatedNCT01032915Phase 3Results posted
• Phase III Study in Refractory Behcet's DiseaseCompletedNCT00995709Phase 3Results posted
• Sirolimus as Therapeutic Approach to UveitisCompletedNCT00908466Phase 1Results posted
• Safety and Efficacy of AIN457 in Noninfectious UveitisCompletedNCT00685399Phase 2Results posted
• A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisCompletedNCT00333814Phase 2/3Results posted
• A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisActive, not recruitingNCT06431373Phase 3
• POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIUTerminatedNCT05953688Phase 2
• The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentCompletedNCT05486468Phase 3
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitisTerminatedNCT05384249Phase 2
• Ozurdex Monotherapy TrialWithdrawnNCT05101928Phase 4
• Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis DiseaseStatus unknownNCT04126850
• Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior PoleActive, not recruitingNCT04120636Phase 1
• Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior PoleActive, not recruitingNCT04120311Phase 1
• ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)CompletedNCT02931175Phase 2
• Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate UveitisCompletedNCT02879084
• Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)TerminatedNCT02375685Phase 3
• An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety DataTerminatedNCT02258854Phase 3
• Safety and Preliminary Efficacy Study of V404 PDS in UveitisTerminatedNCT02125266Phase 1/2
• Safety &Efficacy of CF101 to Subjects With UveitisWithdrawnNCT01905124Phase 2
• Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic TreatmentTerminatedNCT01747538Phase 3
• Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS StudyStatus unknownNCT01717170Phase 1/2
• Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious UveitisTerminatedNCT01684345Phase 3
• Study to Evaluate the Long Term Use of Treatment With AIN457 for UveitisWithdrawnNCT01327664Phase 3
• Intravitreal Sirolimus as Therapeutic Approach to UveitisWithdrawnNCT01280669Phase 2
• Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With PapilloedemaCompletedNCT01170481
• Immunogenetic Mechanisms in Behcet's DiseaseTerminatedNCT01109433
• Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisWithdrawnNCT01103024Phase 3
• Myfortic for the Treatment of Non-infectious Intermediate UveitisCompletedNCT01092533Phase 3
• The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon GammaCompletedNCT00943982Phase 1
• Retisert and Cataract Surgery in Patients With Severe UveitisCompletedNCT00570830Not applicable
• Human Samples and Data RepositoryTerminatedNCT00539370
• A Phase I/IIa Study for the Treatment of Uveitis With IontophoresisWithdrawnNCT00499551Phase 1/2
• A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-UveitisCompletedNCT00404742Phase 3
• A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-UveitisCompletedNCT00404612Phase 3
• Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate UveitisCompletedNCT00344253Phase 3
• The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory DiseaseCompletedNCT00331331
• Leflunomide to Treat UveitisCompletedNCT00001863Phase 2
• Vascular Endothelial Growth Factor (VEGF) in UveitisCompletedNCT00001738

← Uveitis, Intermediate overview